Check out our latest #whitepaper containing clinical trial data, real-world evidence, and example algorithms that detail how T2Candida can be incorporated into practice and improve care for invasive candidiasis in your own practice.
In both of these clinical case studies, T2Bacteria identified the causative pathogen days sooner than blood culture and allowed for the earlier initiation of targeted therapy.